Choroidal Neovascularization Market by Product Type, Distribution Channel, End User 2024-2032
                     Global Choroidal 
Neovascularization 
Market Research and 
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
Acco r d ing  t o  t h e  l a t es t  r epo r t  by  I M ARC  G r oup ,  t i t l ed  " C horo i da l  
Neov ascu l a r i z a t i on  M ar ke t :  G l oba l  I ndu st ry  T rend s ,  Sh are ,  S i ze ,  G row t h ,  
O pp or t u n i t y  and  F oreca s t  20 24 - 20 32 , "  t he  g loba l  c ho r o id a l  neo vasc u la r i za t i on  
m ar ke t  s i ze  r each ed  US $  6 . 5  B i l l i o n  i n  2 023 .
Cho r o ida l  neo vas cu la r i z a t i on  ( CNV)  i s  a  co nd i t i o n  wh e r e  abn o r m a l  new  b lo od  
Report vess e l s  g r ow  i n  t he  o f  t he  eye  u nde r  t he  r e t i na .  Th i s  he a l t h  i s s ue  i s  a  s ign i f i c an t  
con ce r n  i n  eye  ca r e  as  i t  c an  l ead  t o  seve r e  v i s io n  l oss ,  o f t en  l i nked  t o  age - r e la t ed  
Highlight and m ac u la r  d egen e r a t i on  ( AM D) .  
CN wh en  t h ese  i r r egu l a r  b lo od  ve sse l s  b r eak  t h r oug h  t he  B r uch ' s  m e m br a ne ,  a  
f r ag i l e  ba r r i e r  sepa r a t i ng  t he  cho r o id  f r o m  t he  r e t i na ,  ca us ing  f l u i d  o r  b lood  t o  le ak  
Description i n t o  t h e  m ac  t he  cen t r a l  pa r t  o f  t he  r e t i n a  r espon s ib le  f o r  Th e  bu i l d - up  o f  f l u i d  and  
b lood  d i s r u p t s  no r m a l  m acu la r  f unc t i on ,  r esu l t i ng  i n  d i s t o r t ed  o r  b lu r r ed  v i s i on .  CNV 
can  m an i f es t  i n  d i f f e r en t  t yp es ,  such  as  c la ss i c  C NV,  o ccu l t  CNV,  and  m in im a l l y  
c l ass i c  CN V.
Reque st  f o r  a  PDF  sam pl e  o f  t h i s  re por t :  
h t t p s : / / www. im ar c g r ou p . com / cho r o ida l - neov ascu la r i za t i on - m ar k e t / r e ques t sam p le
Report Description
Global  Choro idal  Neovascular izat ion  Market  Trends:
The g loba l  d r iven  by  the  inc reas ing,  wh ich  is  lead ing to  a  h igher  inc idence  o f  age- re la ted macu la r  
degenera t ion  and  assoc ia ted  cond i t ions l ike  CNV.  As  a  resu l t ,  there  i s  a  g rowing demand for  accurate  
d iagnos t ic  too ls  and e f fec t i ve  t rea tment  opt ions,  wh ich i s  expected to  in tens i fy  as  the g loba l  popu la t ion  
cont inues to  age .  Advances in  d iagnost ic  techno log ies ,  such as  OCT and FA imaging,  are  improv ing the  
de tec t ion and d iagnos is  o f  CNV,  enab l ing  t ime ly  in te rvent ions l ike  an t i -VEGF therap ies .  
Compan ies  that  spec ia l ize  in  innova t ive  d iagnos t ic  so lu t ions and  imag ing  equ ipment  are  we l l -pos i t ioned  to  
cap i ta l i ze  on th is  t rend .  The  sh i f t  towards persona l i zed med ic ine  i s  a lso  in f luenc ing  the  CNV marke t ,  w i th  
t rea tment  s t ra teg ies  be ing  ta i lo red  to  ind iv idua l  pa t ient  charac te r is t i cs ,  such  as  genet ic  pro f i les  and  
b iomarkers ,  to  op t im ize outcomes and min imize  s ide e f fec ts .  Fur thermore ,  to  e f fec t i ve  CNV t rea tments ,  
implement ing  in i t ia t i ves  to  s imp l i f y  therapy  approva l  processes and  enhance re imbursement  sys tems.
View Report  TOC,  F igures and Tables :  h t tps: / /www. imarcgroup.com/choroida l -neovascular izat ion-market
Breakup by Product Type:
• Intravenous
• Intravit real
 
Breakup by Type of Diagnosis:
• Fluorescein Angiography (FA)
• Indocyanine Green ( ICG) Angiography
Report • Spectral  Domain Optical  Coherence 
Tomography (OCT)
Segmentation
• Others
Breakup by Treatment Type:
• Angiogenesis Inhibitors In ject ion
• Photodynamic Therapy
• Laser photocoagulat ion
• Low-dose Radiation Therapy
• Surgery
Breakup by Application:
• Extreme Myopia
• Malignant Myopic Degeneration
Report • Age-Related Developments
Segmentation
Breakup by Region:
• North America
• Asia-Pacifi c
• Europe
• Latin America
• Middle East and Afr ica
• Bausch Health Companies Inc.
• Bayer AG
• Gilead Sciences, Inc.
Competitive • F. Hoff mann-La Roche AG
• MaaT Pharma
Landscape 
• Novart is AG
with Key • Pfi zer Inc.
Players • Quark Pharmaceuticals Inc. (SBI 
ALApharma Co. Limited)
• Regeneron Pharmaceuticals Inc.
• Sanwa Kagaku Kenkyusho Co. Ltd. 
(Suzuken Co. Ltd.) .
How has the global choroidal neovascularization market 
performed so far and how will it perform in the coming 
years?
What has been the impact of COVID-19 on the global 
choroidal neovascularization market?
Key 
Questions What are the key regional markets?
Answered in 
What is the breakup of the market based on the product 
the Report type?
What is the breakup of the market based on the type of 
diagnosis?
What is the breakup of the market based on the treatment 
type?
What is the breakup of the market based on the application?
What are the various stages in the value chain of the 
industry?
Key 
Questions What are the key driving factors and challenges in the 
industry?
Answered in 
the Report What is the structure of the global choroidal 
neovascularization market and who are the key players?
What is the degree of competition in the industry?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
        2 . 4 . 1     B o t t o m - U p  A p p r o a c h
Table of         2 . 4 . 2     T o p - D o w n  A p p r o a c h    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
    4 . 1     O v e r v i e w
Contents     4 . 2     K e y  I n d u s t r y  T r e n d s5     G l o b a l  C h o r o i d a l  N e o v a s c u l a r i z a t i o n  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  P r o d u c t  T y p e
    6 . 1     I n t r a v e n o u s
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  M a r k e t  F o r e c a s t
    6 . 2     I n t r a v i t r e a l
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  M a r k e t  F o r e c a s t
7    M a r k e t  B r e a k u p  b y  T y p e  o f  D i a g n o s i s
    7 . 1     F l u o r e s c e i n  A n g i o g r a p h y  ( F A )
        7 . 1 . 1  M a r k e t  T r e n d s
        7 . 1 . 2  M a r k e t  F o r e c a s t
       
    7 . 2     I n d o c y a n i n e  G r e e n  ( I C G )  A n g i o g r a p h y
        7 . 2 . 1  M a r k e t  T r e n d s
        7 . 2 . 2  M a r k e t  F o r e c a s t
    7 . 3     S p e c t r a l  D o m a i n  O p t i c a l  C o h e r e n c e  T o m o g r a p h y  ( O C T )
        7 . 3 . 1  M a r k e t  T r e n d s
        7 . 3 . 2  M a r k e t  F o r e c a s t
    7 . 4     O t h e r s
        7 . 4 . 1  M a r k e t  T r e n d s
        7 . 4 . 2  M a r k e t  F o r e c a s t
8    M a r k e t  B r e a k u p  b y  T r e a t m e n t  T y p e
    8 . 1     A n g i o g e n e s i s  I n h i b i t o r s  I n j e c t i o n
Table of         8 . 1 . 1  M a r k e t  T r e n d s        8 . 1 . 2  M a r k e t  F o r e c a s t
    8 . 2     P h o t o d y n a m i c  T h e r a p y
        8 . 2 . 1  M a r k e t  T r e n d s
Contents         8 . 2 . 2  M a r k e t  F o r e c a s t    8 . 3     L a s e r  P h o t o c o a g u l a t i o n
        8 . 3 . 1  M a r k e t  T r e n d s
        8 . 3 . 2  M a r k e t  F o r e c a s t
    8 . 4     L o w - d o s e  R a d i a t i o n  T h e r a p y
        8 . 4 . 1  M a r k e t  T r e n d s
        8 . 4 . 2  M a r k e t  F o r e c a s t
    8 . 5     S u r g e r y
        8 . 5 . 1  M a r k e t  T r e n d s
        8 . 5 . 2  M a r k e t  F o r e c a s t
9    M a r k e t  B r e a k u p  b y  A p p l i c a t i o n
    9 . 1     E x t r e m e  M y o p i a
        9 . 1 . 1  M a r k e t  T r e n d s
        9 . 1 . 2  M a r k e t  F o r e c a s t     
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
ht t ps : / /w ww. i ma rc gro up . c o m /c ho ro i da l - neo va sc u l a r i z a t i o n -m a
rke t / t o c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: